Tamoxifen (20mg) |
PRODUCT INTRODUCTION | Mamofen 20 Tablet is an anti-estrogens. It is used in the treatment of breast cancer. It is also used to reduce the risk of breast cancer in pre- and postmenopausal women with a high risk. This medicine helps to slow down the growth and multiplication of cancer cells. |
USES OF Monofen 20mg Tab | Breast cancer |
SKU: MF-2443-EX0RC
Categories: Erectile Dysfunction
PRODUCT INTRODUCTION | Mamofen 20 Tablet is an anti-estrogens. It is used in the treatment of breast cancer. It is also used to reduce the risk of breast cancer in pre- and postmenopausal women with a high risk. This medicine helps to slow down the growth and multiplication of cancer cells. |
USES OF Monofen 20mg Tab | Breast cancer |
BENEFITS OF Monofen 20mg Tab | Mamofen 20 Tablet relieves the symptoms of breast cancer such as breast lumps, bloody discharge from nipple or changes in the shape or texture of the breast. It works by altering the production of those hormones in the body that are essential for the growth and spread of breast cancer, both in pre as well as postmenopausal women. It may also interact with other hormones or have a direct effect on the cancer to stop its growth. |
SIDE EFFECTS OF Monofen 20mg Tab | Vaginal bleeding Mood swings Hot flashes Nausea Fluid retention |
HOW TO USE Monofen 20mg Tab | Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Mamofen 20 Tablet may be taken with or without food, but it is better to take it at a fixed time. |
HOW Monofen 20mg Tab WORKS | Mamofen 20 Tablet is a hormone-based medication. It works by binding to estrogen receptors and blocking the effects of estrogen (a natural female hormone) in the breast tissue. This slows down the growth and multiplication of breast cancer cells. |
SAFETY ADVICE | Alcohol Pregnancy Breast feeding Driving Kidney Liver |
Your email address will not be published. Required fields are marked *
Please login to write review!
Looks like there are no reviews yet.